# Mankind Pharma Ltd (MANKIND)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹2514.1
Day Change: -2.7%
52W High: ₹2726.75
52W Low: ₹1909.9
Market Cap: ₹1,03,368 Cr

## Valuation
P/E: 58.14
P/B: 6.76
EPS: ₹43.07
Book Value: ₹370.26
Dividend Yield: 0%

## Returns
1Y Return: 9.94%

## Profitability
ROE: 0%
ROCE: 12.55%
Debt/Equity: 0.54
Revenue Growth: 10.4%
Profit Growth: 4.8%
EBITDA Margin: 23.24%
Operating Margin: 19.53%

## About
Mankind Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Mankind Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Credit Rating
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- BSE Filing: Announcement under Regulation 30 (LODR)-Credit Rating

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:58:03.184Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:03.184Z
Quant Updated: 2026-05-18T22:58:03.184Z
Sentiment Updated: 2026-05-18T22:58:03.184Z
Financials Status: current
Financials Updated: 2026-05-18T02:53:18.262Z
Financials Last Attempt: 2026-05-18T02:53:18.262Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2020)
Revenue: ₹3334 Cr
Operating Profit: ₹586 Cr (OPM 18%)
Net Profit: ₹445 Cr
Tax: ₹621 Cr

## Annual P&L History
Mar 2020: Rev ₹3334Cr | PAT ₹445Cr | OPM 18%
Mar 2021: Rev ₹5865Cr | PAT ₹1056Cr | OPM 25%
Mar 2022: Rev ₹6214Cr | PAT ₹1293Cr | OPM 27%

## Balance Sheet (Mar 2020)
Total Assets: ₹3022 Cr
Total Liabilities: ₹3022 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ramesh C. Juneja, Whole-Time Director & Executive Chairman
- Sheetal  Arora, CEO & Whole-Time Director
- Rajeev  Juneja, Vice Chairman & MD
- Satish Kumar Sharma, Whole-Time Director
- Ashutosh  Dhawan MBA, Chief Financial Officer

---
Source: rupiya.io/stocks/mankind
Disclaimer: For research and education only. Not investment advice.